SANA PHARMA MEDICAL AS
Signals
- Driftsunderskudd 2025 Siste driftsresultat er negativt (−3,6 mill kr).
- Ingen revisor Selskapet har ingen registrert revisor. Vanlig for små AS som har valgt bort revisjon, men verdt å merke seg.
SANA PHARMA MEDICAL AS is registered as a limited company in Bærum, Akershus with organisation number 968671340. The business is classified under wholesale of pharmaceutical and medical goods (NACE 46.460). The company was incorporated in 1994 and has 9 registered employees. Registered share capital is NOK 270,000, divided into 490328 shares. The company's stated purpose is: “Produktutvikling i farmasøytisk industri samt deltakelse i andre foretak.”. The most recent filed accounts, for the 2025 financial year, show NOK 91.7m in revenue and NOK −3.6m in operating profit.
Former names: IMED AS, SANTOSOLVE AS
Key figures · 2025
Financial health · 2025
Who owns SANA PHARMA MEDICAL AS?
SANA PHARMA MEDICAL AS has 1 registered shareholder:
- SANA PHARMA MANAGEMENT AS 100.0%
Which companies does SANA PHARMA MEDICAL AS own?
SANA PHARMA MEDICAL AS holds a stake in 1 company:
- EIR PHARMA AS 100.0%
Frequently asked questions about SANA PHARMA MEDICAL AS
Who owns SANA PHARMA MEDICAL AS?
SANA PHARMA MANAGEMENT AS is the largest registered owner, with 100.0%.
What is the revenue of SANA PHARMA MEDICAL AS?
SANA PHARMA MEDICAL AS had revenue of NOK 91.7m in 2025.
Who is the general manager of SANA PHARMA MEDICAL AS?
Heidi Tveit is registered as general manager of SANA PHARMA MEDICAL AS.
Where is SANA PHARMA MEDICAL AS based?
SANA PHARMA MEDICAL AS has its business address in Lysaker.
Property
18 companies are registered at this address.
The address this company is registered at, from the company register and matched against the cadastre. It does not say who owns the property — a company may be a tenant, and the address is often its accountant's. Source: Brønnøysundregistrene and © Kartverket.
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 02.09.2026.